Progesterone receptor B (PRB) promoter hypermethylation in sporadic breast cancer: Progesterone receptor B hypermethylation in breast cancer

Breast Cancer Research and Treatment

Volumn 111, Issue 1, 2008, Pages 45-53

  Mc Cormack, Orla ^a   Chung, Wen Y ^b   Fitzpatrick, Patricia ^b   Cooke, Fiachra ^b   Flynn, Barbara ^b   Harrison, Michele ^c   Fox, Edward ^b   Gallagher, Emma ^b   McGoldrick, Aloysius ^b   Dervan, Peter A ^c   McCann, Amanda ^b   Kerin, Michael J ^d  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^d UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Breast cancer; Epigenetics; Immunohistochemistry; Oestrogen receptor alpha; Progesterone receptor B; Promoter hypermethylation

Indexed keywords

ANTIBODY; ANTIESTROGEN; BISULFITE; CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; ESTROGEN RECEPTOR ALPHA; GROWTH FACTOR RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; PROTEIN TYROSINE KINASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; DNA EXTRACTION; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NOTTINGHAM PROGNOSTIC INDEX; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SCORING SYSTEM; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; UNIVARIATE ANALYSIS;

BASE SEQUENCE; BREAST NEOPLASMS; DNA METHYLATION; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; PROMOTER REGIONS (GENETICS); RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 47549119087     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9757-7     Document Type: Article

References (22)

1. G Arpino H Weiss AV Lee R Schiff S De Placido CK Osbourne R Elledge 2005 Estrogen receptor-positive, Progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance J Natl Cancer Inst 97 17 1254 1261
2. CA Sartorius MY Melville AR Hovland L Tung GS Takimoto Horwitz 1994 A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform Mol Endocrinol 8 10 1347 1360
3. DP Edwards SE Wardell Boonyaratanakornkit 2002 Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways J Steroid Biochem Mol Biol 83 1-5 173 186
4. B Mulac-Jericevic JP Lydon FJ DeMayo OM Conneely 2003 Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform Proc Natl Acad Sci USA 100 17 9744 9749
5. E Vegeto MM Shahbaz DX Wen ME Goldman BW O'Malley DP McDonnell 1993 Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function Mol Endocrinol 7 10 1244 1255
6. TA Hopp HL Weiss SG Hilsenbeck Y Cui DC Allred KB Horwitz SA Fuqua 2004 Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates Clin Cancer Res 10 8 2751 2760
7. JK Richer BM Jacobsen NG Manning MG Abel DM Wolf KB Horwitz 2002 Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells J Biol Chem 277 7 5209 5218
8. SA Wajed PW Laird TR DeMeester 2001 DNA methylation: an alternative pathway to cancer Ann Surg 234 1 10 20
9. M Widschwendter PA Jones 2002 The potential prognostic, predictive, and therapeutic values of DNA methylation in cancer Clin Cancer Res 8 1 17 21
10. X Yang L Yan NE Davidson 2001 DNA methylation in breast cancer Endocr Relat Cancer 8 2 115 127
11. RG Lapidus AT Ferguson YL Ottaviano FF Parl HS Smith SA Weitzman SB Baylin JP Issa NE Davidson 1996 Methylation of estrogen and progesterone receptor gene 5′ CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors Clin Cancer Res 2 5 805 810
12. M Sasaki A Dharia BR Oh Y Tanaka S Fujimoto R Dahiya 2001 Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer Cancer Res 61 1 97 102
13. M Sasaki Y Tanaka G Perinchery A Dharia I Kotcherguina S Fujimoto R Dahiya 2002 Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer J Natl Cancer Inst 94 5 384 390
14. CW Elston IO Ellis 1991 The value of histological grade in breast cancer: experience from a large study with long term follow up Histopathology 19 403 410
15. R Blamey 1996 The design and clinical use of the Nottingham Prognostic Index in breast cancer Breast 5 156 157
16. J Kiani A Khan H Khawar F Shuaib S Pervez 2006 Estrogen receptor α negative and Progesterone receptor positive breast cancer:lab error or real entity Pathol Oncol Res 12 4 223 227
17. Dowsett M, on behalf of the ATAC Trialist group (2003) Analysis of time to recurrence in the ATAC (Arimidex, tamoxifen, alone or in combination) trial according to estrogen receptor and progesterone receptor status. Breast Cancer Res Treat 82(Suppl 1):S7
18. CK Osborne R Schiff G Arpino AS Lee VG Hilsenbeck 2005 Endocrine responsiveness: Understanding how progesterone receptor can be used to select endocrine therapy Breast 14 458 465
19. RS Punglia KM Kuntz EP Winer JC Weeks HJ Burstein 2006 The impact of tumor Progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early stage breast cancer A decision analysis Cancer 106 2576 2582
20. U Veronesi P Boyle A Goldhirsch R Orecchia G Viale 2005 Breast cancer Lancet 365 9472 1727 1741
21. SR Lakhani 1999 The pathology of familial breast cancer: morphological aspects Breast Cancer Res 1 1 31 35
22. Y Ma P Katiyar LP Jones S Fan Y Zhang PA Furth EM Rosen 2006 The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells Mol Endocrinol 20 1 14 34